Home
Live Updates
NuraLogix Corporation: NuraLogix researchers announce AI models that can predict Blood Biomarker Risk : comparemela.com
NuraLogix Corporation: NuraLogix researchers announce AI models that can predict Blood Biomarker Risk
TORONTO, Aug. 31, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C
Related Keywords
United States ,
Toronto ,
Ontario ,
Canada ,
Keith Thompson ,
Chris Lin ,
Kostenloser Wertpapierhandel ,
Naresh Vempala ,
Research At Nuralogix ,
Fasting Blood Glucose ,
Blood Biomarker ,
Fasting Blood ,
Primary Care Physician ,
Chief Medical Officer ,
Transdermal Optical Imaging ,
Investigational Use ,
Media Inquiries ,
Chief Marketing Officer ,
Nuralogix ,
Corporation ,
Researchers ,
Nnounce ,
Models ,
Redict ,
Flood ,
Biomarker ,
Risk ,
comparemela.com © 2020. All Rights Reserved.